Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Protective effect of Lycium barbarum leaf extracts on atopic dermatitis: in vitro and in vivo studies

  • Han Sol Lee (Department of Food and Nutrition, Chungnam National University) ;
  • Eun Young Bae (Department of Food and Nutrition, Chungnam National University) ;
  • Sun Yung Ly (Department of Food and Nutrition, Chungnam National University)
  • Received : 2022.09.14
  • Accepted : 2023.06.30
  • Published : 2023.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

BACKGROUND/OBJECTIVES: Atopic dermatitis (AD) is a chronic disease with an increasing incidence globally; therefore, there is a growing demand for natural compounds effective in treating dermatitis. In this study, the protective effects of Lycium barbarum leaves with and without chlorophyll (LLE and LLE[Ch-]) on AD were investigated in animal models of AD and HaCaT cells. Further, we investigated whether LLE and LLE(Ch-) show any differences in physiological activity. MATERIALS/METHODS: AD was induced by 2,4-dinitrochlorobenzene (DNCB) for three weeks, while NC/Nga mice were fed LLE or LLE(Ch-) extracts for 7 weeks. Serum immunoglobulin E (IgE) and cytokine (tumor necrosis factor [TNF]-α, interleukin [IL]-6, and IL-4) concentrations and the degree of DNA fragmentation in lymphocytes were examined. A histopathological examination (haematoxylin & eosin staining and blue spots of toluidine) of the dorsal skin of mice was performed. To elucidate the mechanism of action, the expression of the thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) were measured in HaCaT cells. RESULTS: Serum IgE and cytokines (TNF-α and IL-6) levels as well as DNA fragmentation of lymphocytes were significantly decreased in AD-induced mice treated with LLE or LLE(Ch-) compared to those of the control group. The epidermal thickness of the dorsal skin and mast cell infiltration in the LLE group significantly reduced compared to that in the control group. The LLE extracts showed no cytotoxicity up to 1,000 ㎍/mL in HaCaT cells. LLE or LLE(Ch-)-treated group showed a reduction of TARC and MDC in TNF-α-and IFN-γ-stimulated HaCaT cells. CONCLUSIONS: These results suggest that LLE potentially improves inflammation by reducing the expression of chemokines that inhibit T helper 2 cell migration. LLE(Ch-) showed similar effects to LLE on blood levels of IgE, TNF-α and IL-6 and protein expression in HaCat cells, but the ultimate effect of skin improvement was not statistically significant. Therefore, both LLE and LLE(Ch-) can be used as functional materials to alleviate AD, but LLE(Ch-) appears to require more research to improve inflammation.

Keywords

Acknowledgement

The authors thank Professor (Dr.) Eun Mi Park (Hannam University, Daejeon, Republic of Korea) for providing the HaCaT cell line and technical advice.

References

  1. Yang G, Seok JK, Kang HC, Cho YY, Lee HS, Lee JY. Skin barrier abnormalities and immune dysfunction in atopic dermatitis. Int J Mol Sci 2020;21:2867.
  2. Gittler JK, Shemer A, Suarez-Farinas M, Fuentes-Duculan J, Gulewicz KJ, Wang CQ, Mitsui H, Cardinale I, de Guzman Strong C, Krueger JG, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 2012;130:1344-54. https://doi.org/10.1016/j.jaci.2012.07.012
  3. Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014;134:769-79. https://doi.org/10.1016/j.jaci.2014.08.008
  4. Renert-Yuval Y, Thyssen JP, Bissonnette R, Bieber T, Kabashima K, Hijnen D, Guttman-Yassky E. Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council. J Allergy Clin Immunol 2021;147:1174-1190.e1. https://doi.org/10.1016/j.jaci.2021.01.013
  5. Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K, Schikowski T, Proksch E, Elias PM, Simon M, et al. Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci 2021;102:142-57. https://doi.org/10.1016/j.jdermsci.2021.04.007
  6. Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018;32:657-82. https://doi.org/10.1111/jdv.14891
  7. Ye X, Jiang Y. Phytochemicals in Goji Berries. Boca Raton (FL): CRC Press; 2020.
  8. Yao R, Heinrich M, Zhao X, Wang Q, Wei J, Xiao P. What's the choice for goji: Lycium barbarum L. or L. chinense Mill.? J Ethnopharmacol 2021;276:114185.
  9. Zhao XQ, Guo S, Lu YY, Hua Y, Zhang F, Yan H, Shang EX, Wang HQ, Zhang WH, Duan JA. Lycium barbarum L. leaves ameliorate type 2 diabetes in rats by modulating metabolic profiles and gut microbiota composition. Biomed Pharmacother 2020;121:109559.
  10. Mocan A, Zengin G, Simirgiotis M, Schafberg M, Mollica A, Vodnar DC, Crisan G, Rohn S. Functional constituents of wild and cultivated Goji (L. barbarum L.) leaves: phytochemical characterization, biological profile, and computational studies. J Enzyme Inhib Med Chem 2017;32:153-68. https://doi.org/10.1080/14756366.2016.1243535
  11. Ma JF, Zhang H, Teh SS, Wang CW, Zhang Y, Hayford F, Wang L, Ma T, Dong Z, Zhang Y, et al. Goji berries as a potential natural antioxidant medicine: an insight into their molecular mechanisms of action. Oxid Med Cell Longev 2019;2019:2437397.
  12. Paik S, Lee J, Yun TS, Park YC, Lee B, Son S, Ju J. Effects of planting density and cutting height on production of leaves for processing raw materials in goji berry. Korean J Med Crop Sci 2020;28:136-41. https://doi.org/10.7783/KJMCS.2020.28.2.136
  13. Nurhayati N, Suendo V. Isolation of chlorophyll a from spinach leaves and modification of center ion with Zn2+: study on its optical stability. J Matematika Sains 2011;16:65-70.
  14. Solymosi K, Mysliwa-Kurdziel B. Chlorophylls and their derivatives used in food industry and medicine. Mini Rev Med Chem 2017;17:1194-222. https://doi.org/10.2174/1389557516666161004161411
  15. Porrarud S, Pranee A. Microencapsulation of Zn-chlorophyll pigment from Pandan leaf by spray drying and its characteristic. Int Food Res J 2010;17:1031-42.
  16. Kim JE, Bae SM, Nam YR, Bae EY, Ly SY. Antioxidant activity of ethanol extract of Lycium barbarum's leaf with removal of chlorophyll. J Nutr Health 2019;52:26-35. https://doi.org/10.4163/jnh.2019.52.1.26
  17. Bae SM, Kim JE, Bae EY, Kim KA, Ly SY. Anti-inflammatory effects of fruit and leaf extracts of Lycium barbarum in lipopolysaccharide-stimulated RAW264. 7 cells and animal model. J Nutr Health 2019;52:129-38. https://doi.org/10.4163/jnh.2019.52.2.129
  18. Nam KY, Go YE, Lee SY, Lee JS. A study on natural dye having the effects on the atopic dermatitis-Juniperus chinensis heartwood extract. Fibers Polym 2013;14:2045-53. https://doi.org/10.1007/s12221-013-2045-8
  19. Cha KJ, Im MA, Gu A, Kim DH, Lee D, Lee JS, Lee JS, Kim IS. Inhibitory effect of Patrinia scabiosifolia Link on the development of atopic dermatitis-like lesions in human keratinocytes and NC/Nga mice. J Ethnopharmacol 2017;206:135-43. https://doi.org/10.1016/j.jep.2017.03.045
  20. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;35:206-21. https://doi.org/10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
  21. Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch R, Brocker EB, Blaser K, Akdis CA. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 2001;108:839-46. https://doi.org/10.1067/mai.2001.118796
  22. Baugh JA, Bucala R. Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Devel 2001;4:635-50.
  23. Choi Y, Kim MS, Hwang JK. Inhibitory effects of panduratin A on allergy-related mediator production in rat basophilic leukemia mast cells. Inflammation 2012;35:1904-15. https://doi.org/10.1007/s10753-012-9513-y
  24. Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy 2015;45:566-74. https://doi.org/10.1111/cea.12495
  25. Otsuka A, Nomura T, Rerknimitr P, Seidel JA, Honda T, Kabashima K. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunol Rev 2017;278:246-62. https://doi.org/10.1111/imr.12545
  26. Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, El Ghalbzouri A, Bouwstra JA. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J Invest Dermatol 2014;134:1941-50. https://doi.org/10.1038/jid.2014.83
  27. Diehl S, Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002;39:531-6. https://doi.org/10.1016/S0161-5890(02)00210-9
  28. Nguyen SM, Rupprecht CP, Haque A, Pattanaik D, Yusin J, Krishnaswamy G. Mechanisms governing anaphylaxis: inflammatory cells, mediators, endothelial gap junctions and beyond. Int J Mol Sci 2021;22:7785.
  29. Ji H, Li XK. Oxidative stress in atopic dermatitis. Oxid Med Cell Longev 2016;2016:2721469.
  30. Tsukahara H, Shibata R, Ohshima Y, Todoroki Y, Sato S, Ohta N, Hiraoka M, Yoshida A, Nishima S, Mayumi M. Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis. Life Sci 2003;72:2509-16. https://doi.org/10.1016/S0024-3205(03)00145-0
  31. Omata N, Tsukahara H, Ito S, Ohshima Y, Yasutomi M, Yamada A, Jiang M, Hiraoka M, Nambu M, Deguchi Y, et al. Increased oxidative stress in childhood atopic dermatitis. Life Sci 2001;69:223-8. https://doi.org/10.1016/S0024-3205(01)01124-9
  32. Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 2016;138:336-49. https://doi.org/10.1016/j.jaci.2016.06.010
  33. Proksch E, Folster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006;43:159-69. https://doi.org/10.1016/j.jdermsci.2006.06.003
  34. Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. Mast cells in atopic dermatitis. Curr Opin Immunol 2009;21:666-78. https://doi.org/10.1016/j.coi.2009.09.006
  35. Kritas SK, Saggini A, Varvara G, Murmura G, Caraffa A, Antinolfi P, Toniato E, Pantalone A, Neri G, Frydas S, et al. Impact of mast cells on the skin. Int J Immunopathol Pharmacol 2013;26:855-9. https://doi.org/10.1177/039463201302600403
  36. Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006;43:75-84. https://doi.org/10.1016/j.jdermsci.2006.06.002
  37. Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, Shinomiya N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol 2008;19:605-13. https://doi.org/10.1111/j.1399-3038.2007.00692.x
  38. Masci A, Carradori S, Casadei MA, Paolicelli P, Petralito S, Ragno R, Cesa S. Lycium barbarum polysaccharides: extraction, purification, structural characterisation and evidence about hypoglycaemic and hypolipidaemic effects. A review. Food Chem 2018;254:377-89. https://doi.org/10.1016/j.foodchem.2018.01.176
  39. Zhou ZQ, Xiao J, Fan HX, Yu Y, He RR, Feng XL, Kurihara H, So KF, Yao XS, Gao H. Polyphenols from wolfberry and their bioactivities. Food Chem 2017;214:644-54. https://doi.org/10.1016/j.foodchem.2016.07.105
  40. Jin M, Huang Q, Zhao K, Shang P. Biological activities and potential health benefit effects of polysaccharides isolated from Lycium barbarum L. Int J Biol Macromol 2013;54:16-23. https://doi.org/10.1016/j.ijbiomac.2012.11.023
  41. Tian X, Liang T, Liu Y, Ding G, Zhang F, Ma Z. Extraction, structural characterization, and biological functions of Lycium Barbarum polysaccharides: a review. Biomolecules 2019;9:389.
  42. Cheng J, Zhou ZW, Sheng HP, He LJ, Fan XW, He ZX, Sun T, Zhang X, Zhao RJ, Gu L, et al. An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides. Drug Des Devel Ther 2014;9:33-78.